SEATTLE, July 30, 2021, (MEDGADGET) — Global Contrast Media Injectors Market Analysis
Overview
Contrast media injectors are instruments that are used to inject or deliver contrast media into a patient’s body in order to improve tissue exposure prior to a medical imaging operation such as CT scan, MRI scan, ultrasound scan, or X-ray.
By the end of 2027, the global contrast media injectors market is expected to reach US$ 2,000.7 million in size and 49,381 units in production.
Get Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/3157
Drivers
Over the forecast period, rising cancer incidence is expected to drive the growth of the global contrast media injectors market. As per the World Health Organization, cancer is the world’s second leading cause of death, accounting for 9.6 million deaths in 2018.
Furthermore, the government and private sector investment in contrast media injectors, as well as the treatment and control of chronic diseases, is expected to fuel the growth of the global contrast media injectors market. Via the National Health and Medical Research Council’s cooperation with the Global Alliance for Chronic Diseases, the Australian government declared in December 2019 that it would spend US$ 5 million in new funding round for research into cancer primary and secondary prevention.
In 2014, the European region dominated the global contrast media injectors market, contributing towards 37.0 percent of the market share, led by North America.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/contrast-media-injectors-market-2564
Restraints
Over the forecast period, the high cost of contrast media injectors, consumables, and accessories will be a major obstacle to the global contrast media injectors market’s development. CT injectors cost between 30,000 and 40,000 dollars, while MRI injectors cost between 35,000 and 40,000 dollars.
Furthermore, comparison media have a number of side effects, including stomach cramps, fatigue, diarrhea, and vomiting (associated with barium sulphate contrast materials). Headache, flushing, and minor skin rashes are all side effects of iodine-based contrast products. The growth of the global contrast media injectors market is also projected to be hampered by such side effects.
“Limited Time Offer”
Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/3157
Opportunities
To increase their market share, market players should concentrate on developing contrast media injectors with soft bag technology. Soft bag technology in comparison to media injectors has many advantages, including gentle media injection for optimum patient ease, smoother handling, software-guided protocol, shorter handling time, and a lower risk of air emboli development.
Furthermore, market leaders should concentrate on designing better software for better comparison media distribution. Pre-installed protocol, improved accuracy of results, possible improvement in contrast media usefulness, consistent delivery of contrast media, and contrast media control are all benefits of software-guided contrast media injectors.
The CT Injectors segment of the global contrast media injectors market was worth US$ 514.4 million in 2018 and is projected to develop at a CAGR of 6.0 percent to US$ 864.6 million by 2027.
Special Requirements?
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/3157
Market Trends
Syringe-less power injectors are becoming more common in the global contrast media injectors market, owing to benefits such as decreased contrast media waste and higher performance when compared to dual-syringe injectors.
Furthermore, market players are concentrating on product acceptance and launch in order to extend their product range. General Electric obtained FDA approval for Visipaque (iodixanol) injection for use in coronary CT angiography in May 2018.
Competitive Landscape
Key companies contributing to the global contrast media injectors market are Bayer AG, Mallinckrodt, General Electric, Medtron, Nemoto Kyorindo Co. Ltd., Ulrich GmbH & Co. KG, Guerbet SA, and Bracco Imaging S.p.A.
Key Developments
The market’s major players are concentrating on introducing new products in order to extend their product range. At the 2019 Radiological Society of North America (RSNA) Annual Meeting in November 2019, Bracco Diagnostics Inc. unveiled new contrast media and product offerings.
Serena Bright, a contrast-enhanced mammography solution for biopsy, was unveiled by General Electric Healthcare in November 2019.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By Region Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Technological Advancements
- Key Highlights
- Epidemiology
- Regulatory Scenario
- PEST Analysis
- Mergers and Acquisitions
- Market Dynamics
- Global Contrast Media Injectors Market, By Product Type, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- CT Injectors
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million and Units)
- MRI Injectors
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million and Units)
- Cardio Injectors
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million and Units)
- Introduction
- Global Contrast Media Injectors Market, By End User, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospitals
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Diagnostic Centers
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Contrast Media Injectors Market, By Region, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size, Volume, and Forecast, By Product Type, 2016 – 2027, (US$ Million and Units)
- Market Size, Volume, and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size, Volume, and Forecast, By Country, 2016 – 2027, (US$ Mn)
- The U.S.
- Canada
- Latin America
- Market Size, Volume, and Forecast, By Product Type, 2016 – 2027, (US$ Million and Units)
- Market Size, Volume, and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size, Volume, and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size, Volume, and Forecast, By Product Type, 2016 – 2027, (US$ Million and Units)
- Market Size, Volume, and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size, Volume, and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Germany
- The U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size, Volume, and Forecast, By Product Type, 2016 – 2027, (US$ Million and Units)
- Market Size, Volume, and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size, Volume, and Forecast, By Country, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size, Volume, and Forecast, By Product Type, 2016 – 2027, (US$ Million and Units)
- Market Size, Volume, and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size, Volume, and Forecast, By Country, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of the Middle East
- Africa
- Market Size, Volume, and Forecast, By Product Type, 2016 – 2027, (US$ Million and Units)
- Market Size, Volume, and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size, Volume, and Forecast, By Country, 2016 – 2027, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
Have a Look at Related Research Insights:
Auto-Injectors Market To Surpass US$ 7,894.6 Million By 2027
Injectable Drug Delivery Market To Surpass US$ 32.5 Billion By 2026
Biobanking Equipment Market To Surpass US$ 3.2 Billion By 2026
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837